SAFETY OF JAK INHIBITORS IN PATIENTS WITH ARTHRITIS RHEUMATOID UNDER REAL-LIFE CONDITIONS

dc.conference.dateJUN 03, 2020
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorVelloso Feijoo, M. L.
dc.contributor.authorCid Boza, N.
dc.contributor.authorPerez, M. J.
dc.contributor.authoraffiliation[Velloso Feijoo, M. L.] Hosp Valme, Seville, Spain
dc.contributor.authoraffiliation[Cid Boza, N.] Hosp Valme, Seville, Spain
dc.contributor.authoraffiliation[Perez, M. J.] Hosp Valme, Seville, Spain
dc.date.accessioned2025-01-07T15:25:59Z
dc.date.available2025-01-07T15:25:59Z
dc.date.issued2020-06-01
dc.identifier.doi10.1136/annrheumdis-2020-eular.6615
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/79/Suppl_1/1482.2.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/27146
dc.identifier.wosID555905004596
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de Valme
dc.page.number1478-1478
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleSAFETY OF JAK INHIBITORS IN PATIENTS WITH ARTHRITIS RHEUMATOID UNDER REAL-LIFE CONDITIONS
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number79
dc.wostypeMeeting Abstract

Files